Combinations of a H3 antagonist and a noradrenaline reuptake inhibitor, and the therapeutical uses thereof
US12059416B2 · kind B2 · utility
0Cited by
1References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 26, 2021 |
| Grant date | Aug 13, 2024 |
| Priority date | — |
| Expiry date | Mar 14, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/26
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are combinations of a H3 antagonist and an antidepressant, which exhibit a synergistic wake promoting activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.